JP2020527134A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020527134A5 JP2020527134A5 JP2019572791A JP2019572791A JP2020527134A5 JP 2020527134 A5 JP2020527134 A5 JP 2020527134A5 JP 2019572791 A JP2019572791 A JP 2019572791A JP 2019572791 A JP2019572791 A JP 2019572791A JP 2020527134 A5 JP2020527134 A5 JP 2020527134A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- wound
- burn
- formulation
- mefp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2017/091819 | 2017-07-05 | ||
| CN2017091819 | 2017-07-05 | ||
| CNPCT/CN2018/087058 | 2018-05-16 | ||
| CN2018087058 | 2018-05-16 | ||
| PCT/CN2018/094441 WO2019007356A1 (en) | 2017-07-05 | 2018-07-04 | TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MOLD ADHESION PROTEINS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020527134A JP2020527134A (ja) | 2020-09-03 |
| JP2020527134A5 true JP2020527134A5 (cg-RX-API-DMAC7.html) | 2021-08-12 |
| JP7288404B2 JP7288404B2 (ja) | 2023-06-07 |
Family
ID=64949737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019572791A Active JP7288404B2 (ja) | 2017-07-05 | 2018-07-04 | モンテルカストおよびイガイ接着タンパク質との組み合わせを含む局所製剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11672792B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3648767A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7288404B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102785243B1 (cg-RX-API-DMAC7.html) |
| CN (3) | CN110312513B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018295944B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3068818A1 (cg-RX-API-DMAC7.html) |
| MA (1) | MA52924A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020000029A (cg-RX-API-DMAC7.html) |
| MY (1) | MY201703A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201911841PA (cg-RX-API-DMAC7.html) |
| TW (1) | TWI874298B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019007356A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3068818A1 (en) * | 2017-07-05 | 2019-01-10 | Jiangyin Mucocare Pharmaceutical Co., Ltd | Topical formulations comprising montelukast and combinations with mussel adhesive proteins |
| HUE062848T2 (hu) * | 2018-09-14 | 2023-12-28 | Enlitisa Shanghai Pharmaceutical Co Ltd | Montelukaszt és peptidek konjugátumai |
| WO2020143744A1 (en) * | 2019-01-10 | 2020-07-16 | Jiangyin Mucocare Pharmaceutical Co., Ltd. | New formulations containing leukotriene receptor antagonists |
| EP4028409A4 (en) * | 2019-09-14 | 2023-10-11 | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | NEW PEPTIDES |
| KR20220119051A (ko) * | 2019-12-02 | 2022-08-26 | 엔리티사 (상하이) 파마슈티컬 컴퍼니 리미티드 | 신규한 다기능성 올리고펩타이드 |
| US20240218016A1 (en) * | 2019-12-02 | 2024-07-04 | Shenzhen Institutes Of Advanced Technology | Peptides and their use in the treatment of inflammation |
| JP7314421B2 (ja) * | 2020-02-03 | 2023-07-25 | タロー・ファーマシューティカル・インダストリーズ・リミテッド | 局所用モンテルカスト製剤 |
| US12233055B2 (en) | 2020-02-03 | 2025-02-25 | Taro Pharmaceutical Industries Ltd. | Topical Montelukast formulations |
| US20230372324A1 (en) | 2020-10-13 | 2023-11-23 | Diomed Developments Ltd. | Gel formulations comprising montelukast |
| CN114588267A (zh) * | 2020-12-04 | 2022-06-07 | 江苏恒瑞医药股份有限公司 | 一种含酰胺类局部麻醉药的药物组合物 |
| WO2022193186A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New diagnostic and therapeutic agents |
| WO2022193185A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New conjugates |
| CN117794539A (zh) * | 2021-08-06 | 2024-03-29 | 艾缇亚(上海)制药有限公司 | 免疫缺陷障碍的新治疗 |
| CN116421547A (zh) * | 2023-03-09 | 2023-07-14 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 一种孟鲁司特钠外用乳膏剂的制备及其在炎症性皮肤病中的应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997024112A1 (en) * | 1995-12-28 | 1997-07-10 | Yoshitomi Pharmaceutical Industries, Ltd. | External preparation |
| US20030207932A1 (en) * | 2002-05-03 | 2003-11-06 | Morris Mann | Compositions that prevent post-traumatic hyperpigmentation and methods related thereto |
| ES2375565T3 (es) * | 2003-08-07 | 2012-03-02 | Healor Ltd. | Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas. |
| US6987170B1 (en) * | 2004-08-09 | 2006-01-17 | Battelle Energy Alliance, Llc | Cloning and expression of recombinant adhesive protein Mefp-1 of the blue mussel, Mytilus edulis |
| WO2007126865A2 (en) * | 2006-03-30 | 2007-11-08 | Patrin Pharma | Leukotriene antagonists via nasal drug delivery |
| CN1961867A (zh) * | 2006-11-16 | 2007-05-16 | 徐英权 | 孟鲁司特钠的颗粒剂型 |
| WO2008105803A1 (en) * | 2007-02-26 | 2008-09-04 | Larry Schlesinger | Topical formulations containing leukotriene receptor antagonist and uses thereof |
| WO2008106081A1 (en) | 2007-02-26 | 2008-09-04 | Larry Schlesinger | Topical formulations containing leukotriene receptor antagonist and use for treatment or prevention of capsular contracture, scarring or hyperpigmentation |
| WO2009137555A1 (en) * | 2008-05-06 | 2009-11-12 | Schlesinger S Larry | Topical and injectable formulations comprising leukotriene receptor antagonist and uses thereof |
| CA2653011A1 (en) * | 2008-12-03 | 2010-06-03 | Apotex Technologies Inc | Method and apparatus for packaging and dispensing pharmaceuticals |
| GB0915319D0 (en) | 2009-09-03 | 2009-10-07 | Sharma Anant | Combination medicament |
| CN101773503A (zh) * | 2010-01-12 | 2010-07-14 | 北京华禧联合科技发展有限公司 | 一种白三烯拮抗剂和抗组胺药组合物 |
| ES2705244T3 (es) * | 2010-06-16 | 2019-03-22 | Inflammatory Response Res Inc | Levocetirizina y montelukast para el tratamiento de la gripe y del resfriado común |
| CN102895661A (zh) * | 2011-07-28 | 2013-01-30 | 中国科学院上海药物研究所 | 靶向CysLT1的药物在制备用于预防或治疗自身免疫性疾病的药物中的用途 |
| CN104168892B (zh) | 2011-12-26 | 2017-06-30 | Sk化学公司 | 用于口腔施用的含有孟鲁司特或其可药用盐的膜 |
| CN103239450B (zh) | 2012-02-07 | 2014-11-26 | 齐鲁制药有限公司 | 一种能快速溶出、稳定的孟鲁司特钠口服固体制剂及其制备方法 |
| ES2660494T3 (es) * | 2013-03-13 | 2018-03-22 | 14779507 | Uso de levocetirizina y montelukast en el tratamiento de una lesión traumática |
| CN103655497B (zh) * | 2013-12-18 | 2018-05-29 | 北京华禧联合科技发展有限公司 | 一种孟鲁司特钠口腔崩解片及其制备方法 |
| CN106573048B (zh) * | 2014-08-04 | 2021-11-09 | 日东电工株式会社 | 体液免疫诱导促进用组合物和疫苗药物组合物 |
| CN105769825A (zh) | 2014-12-24 | 2016-07-20 | 广州朗圣药业有限公司 | 一种孟鲁司特钠的口腔膜剂及其制备方法 |
| CN105878215A (zh) | 2014-12-31 | 2016-08-24 | 天津康鸿医药科技发展有限公司 | 一种稳定的孟鲁司特口腔速溶膜及其制备方法和用途 |
| WO2016148455A2 (ko) * | 2015-03-13 | 2016-09-22 | 경희대학교 산학협력단 | 몬테루카스트의 생체이용률을 개선시키기 위한 방법 |
| CN104784157B (zh) | 2015-04-04 | 2018-06-26 | 齐鲁制药有限公司 | 一种稳定的孟鲁司特口腔薄膜剂 |
| BR112018000953A2 (pt) * | 2015-07-20 | 2018-09-11 | Bengt I. Samuelsson Institute Of Life Science Research | produto de proteína adesiva de mexilhão e aplicações do mesmo na supressão de inflamações de pele |
| WO2017011983A1 (zh) * | 2015-07-20 | 2017-01-26 | 江阴市本特塞缪森生命科学研究院有限公司 | 贻贝粘蛋白用于皮肤和皮肤附属器官的防护 |
| WO2017147067A1 (en) * | 2016-02-22 | 2017-08-31 | Board Of Regents, The University Of Texas System | Antimicrobial compositions and uses thereof |
| US10548837B1 (en) | 2016-05-04 | 2020-02-04 | Taro Pharmaceutical Industries Ltd. | Topical montelukast for treatment of atopic dermatitis |
| CA3068818A1 (en) * | 2017-07-05 | 2019-01-10 | Jiangyin Mucocare Pharmaceutical Co., Ltd | Topical formulations comprising montelukast and combinations with mussel adhesive proteins |
| MA52794A (fr) * | 2018-05-28 | 2021-04-14 | Jiangyin Usun Pharmaceutical Co Ltd | Nouvelle utilisation pharmaceutique |
| HUE062848T2 (hu) * | 2018-09-14 | 2023-12-28 | Enlitisa Shanghai Pharmaceutical Co Ltd | Montelukaszt és peptidek konjugátumai |
| WO2020143744A1 (en) * | 2019-01-10 | 2020-07-16 | Jiangyin Mucocare Pharmaceutical Co., Ltd. | New formulations containing leukotriene receptor antagonists |
-
2018
- 2018-07-04 CA CA3068818A patent/CA3068818A1/en active Pending
- 2018-07-04 CN CN201880002883.6A patent/CN110312513B/zh active Active
- 2018-07-04 MA MA052924A patent/MA52924A/fr unknown
- 2018-07-04 CN CN202110903665.3A patent/CN113491696A/zh active Pending
- 2018-07-04 EP EP18827979.8A patent/EP3648767A4/en active Pending
- 2018-07-04 KR KR1020207003363A patent/KR102785243B1/ko active Active
- 2018-07-04 MY MYPI2020000043A patent/MY201703A/en unknown
- 2018-07-04 US US16/628,170 patent/US11672792B2/en active Active
- 2018-07-04 WO PCT/CN2018/094441 patent/WO2019007356A1/en not_active Ceased
- 2018-07-04 JP JP2019572791A patent/JP7288404B2/ja active Active
- 2018-07-04 AU AU2018295944A patent/AU2018295944B2/en active Active
- 2018-07-04 MX MX2020000029A patent/MX2020000029A/es unknown
- 2018-07-04 SG SG11201911841PA patent/SG11201911841PA/en unknown
- 2018-07-04 CN CN202210843681.2A patent/CN115300508A/zh active Pending
- 2018-07-05 TW TW107123334A patent/TWI874298B/zh active
-
2023
- 2023-05-01 US US18/310,020 patent/US20230404992A1/en not_active Abandoned
-
2024
- 2024-12-11 US US18/977,212 patent/US20250302818A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10568938B2 (en) | Mussel adhesive protein product and applications thereof in suppression of skin inflammations | |
| US20130052273A1 (en) | Pharmaceutical composition comprising periplaneta americana or its ethanol extract and a method of using the same for treating inflammations | |
| CN105142728A (zh) | 用于治疗表面创伤的组合物和方法 | |
| US11696907B2 (en) | Wound healing composition | |
| DK2691103T3 (en) | METHOD FOR treating skin conditions | |
| ES2901419T3 (es) | Medicamento tópico para lesiones de la piel y las mucosas asociadas con epidermólisis ampollosa | |
| AR119031A1 (es) | Formulaciones farmacéuticas antibacterianas de amplio espectro que comprenden lisozima y métodos de utilización de la misma | |
| US11045503B2 (en) | Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis | |
| CN106456600B (zh) | 使用青蒿素及其衍生物治疗或预防脂溢性角化病 | |
| AU2015349153B2 (en) | Application of levalbuterol formulation in treatment of skin and mucous membrane traumatic ulcers | |
| US11260111B2 (en) | Mussel adhesive protein product and applications thereof in suppression of skin inflammations | |
| WO2017220845A1 (es) | Composiciones para el tratamiento de estrías y úlceras de origen isquémico | |
| Al-lethie et al. | Evaluation of clinical recovery and healing of oral lesions by 3 different therapeutic regimens in cattle with foot and mouth disease (FMD) | |
| Hill et al. | Molluscum contagiosum cured with sulfapyridine | |
| KR20200075335A (ko) | 피부병 치료제 | |
| CN117100818A (zh) | 一种治疗痔疮的外用膏剂及其制备方法 | |
| US20190000822A1 (en) | Chlorine or bromine salts of cetylpyridinium for use in the treatment of cutaneous and acute porphyrias and psoriasis | |
| Bachot et al. | Deep peels | |
| HK1254527A1 (zh) | 药物调配物和其用途 | |
| Ashurst | A Manual of Clinical Dermatology | |
| CN110403983A (zh) | 一种治疗痔疮的天然产物组合物及其制备方法 | |
| ALLEN | DISEASES OF THE SKIN. | |
| Chakravorty et al. | Some Observations in the Use of Halogen Substituted Derivatives of Quinoline in Dermatological Practice | |
| Wise et al. | MANHATTAN DERMATOLOGIC SOCIETY | |
| HK1231780B (en) | Treatment or prevention of seborrheic keratosis using artemisinin and derivatives thereof |